Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2023-09-21 00:00:00 ET · period of report 2023-09-20 · accession 0000950170-23-049302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2023-09-21 | 2023-09-20+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $250.05 | -127.3K | 5.91M | -2% | -$31.83M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-20 | S | D | 65,653 | $255.48 | 5,976,602 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $253.07 to $257.935. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2023-09-21 | S | D | 61,655 | $244.27 | 5,914,947 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $239.77 to $251.58. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |